default author photo

Alexander M. Menzies

The University of Sydney - Melanoma Institute Australia

Sydney

Australia

  • The University of Sydney - Melanoma Institute Australia

SCHOLARLY PAPERS

1

DOWNLOADS

43

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Real-World Outcomes with Ipilimumab and Nivolumab in Advanced Melanoma: A Multicentre Retrospective Study

Number of pages: 20 Posted: 31 Mar 2022
Patricio Serra-Bellver, Judith M. Versluis, Honey K. Oberoi, Cong Zhou, Timothy D. Slattery, Yasir Khan, James R. Patrinely, Ines Pires da Silva, Clara Martinez-Vila, Natalie Cook, Donna Graham, Matteo Carlino, Alexander M. Menzies, Ana M. Arance, Douglas B. Douglas, Georgina V. Long, Lisa Pickering, James M. G. Larkin, Christian U. Blank and Paul Lorigan
Manchester Academic Health Sciences Centre - The Christie NHS Foundation Trust, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, The University of Sydney - Melanoma Institute Australia, affiliation not provided to SSRN, The University of Manchester, The Christie NHS Foundation Trust, Blacktown Hospital, The University of Sydney - Melanoma Institute Australia, Hospital of Barcelona, Vanderbilt University - Vanderbilt-Ingram Cancer Center, The University of Sydney - Melanoma Institute Australia, Royal Marsden NHS Foundation Trust - Renal and Skin Units, NHS Foundation Trust - Royal Marsden Hospital, Netherlands Cancer Institute and The University of Manchester
Downloads 43 (1,145,425)

Abstract:

Loading...

melanoma, real-world, ipilimumab+nivolumab, immunotherapy